Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P26
Within normal range
vs 5Y Ago
-2.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -12.82% |
| Q3 2025 | -7.14% |
| Q2 2025 | -37.31% |
| Q1 2025 | 71.79% |
| Q4 2024 | -18.75% |
| Q3 2024 | 0.00% |
| Q2 2024 | 2.13% |
| Q1 2024 | 30.56% |
| Q4 2023 | -12.20% |
| Q3 2023 | -14.58% |
| Q2 2023 | 20.00% |
| Q1 2023 | 42.86% |
| Q4 2022 | 40.00% |
| Q3 2022 | -13.04% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | -45.24% |
| Q3 2021 | 90.91% |
| Q2 2021 | 15.79% |
| Q1 2021 | 0.00% |
| Q4 2020 | 5.56% |
| Q3 2020 | 63.64% |
| Q2 2020 | -8.33% |
| Q1 2020 | -7.69% |
| Q4 2019 | -23.53% |
| Q3 2019 | 0.00% |
| Q2 2019 | 21.43% |
| Q1 2019 | 27.27% |
| Q4 2018 | -35.29% |
| Q3 2018 | 41.67% |
| Q2 2018 | -25.00% |
| Q1 2018 | 33.33% |
| Q4 2017 | -14.29% |
| Q3 2017 | -12.50% |
| Q2 2017 | 6.67% |
| Q1 2017 | 72.81% |
| Q4 2016 | -12.06% |
| Q3 2016 | 37.08% |
| Q2 2016 | -48.57% |
| Q1 2016 | 192.89% |